vs
COLONY BANKCORP INC（CBAN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是COLONY BANKCORP INC的1.9倍（$75.5M vs $39.9M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 19.6%）
Colony Bankcorp Inc是总部位于美国的银行控股公司，旗下运营Colony Bank，主要面向佐治亚州的个人消费者与中小企业，提供储蓄账户、贷款、抵押及财富管理等全方位个人及商业金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CBAN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$39.9M
两年增速更快
PBYI
近两年复合增速
19.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.9M | $75.5M |
| 净利润 | $8.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 20.6% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 24.1% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBANPBYI
| Q1 26 | $39.9M | — | ||
| Q4 25 | $36.9M | $75.5M | ||
| Q3 25 | $32.8M | $54.5M | ||
| Q2 25 | $32.5M | $52.4M | ||
| Q1 25 | $30.0M | $46.0M | ||
| Q4 24 | $30.8M | $59.1M | ||
| Q3 24 | $28.6M | $80.5M | ||
| Q2 24 | $27.9M | $47.1M |
净利润CBANPBYI
| Q1 26 | $8.2M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $5.8M | $8.8M | ||
| Q2 25 | $8.0M | $5.9M | ||
| Q1 25 | $6.6M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $5.6M | $20.3M | ||
| Q2 24 | $5.5M | $-4.5M |
毛利率CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | 25.9% | 22.7% | ||
| Q3 25 | 22.2% | 17.6% | ||
| Q2 25 | 30.9% | 12.7% | ||
| Q1 25 | 27.6% | 8.7% | ||
| Q4 24 | 28.8% | 22.6% | ||
| Q3 24 | 24.6% | 27.4% | ||
| Q2 24 | 24.8% | -4.6% |
净利率CBANPBYI
| Q1 26 | 20.6% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 17.7% | 16.2% | ||
| Q2 25 | 24.6% | 11.2% | ||
| Q1 25 | 22.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.7% | 25.2% | ||
| Q2 24 | 19.6% | -9.6% |
每股收益（稀释后）CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | $0.42 | $0.26 | ||
| Q3 25 | $0.33 | $0.17 | ||
| Q2 25 | $0.46 | $0.12 | ||
| Q1 25 | $0.38 | $0.06 | ||
| Q4 24 | $0.43 | $0.40 | ||
| Q3 24 | $0.32 | $0.41 | ||
| Q2 24 | $0.31 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $295.8M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $380.4M | $130.3M |
| 总资产 | $3.7B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CBANPBYI
| Q1 26 | $295.8M | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | $258.1M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $248.0M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益CBANPBYI
| Q1 26 | $380.4M | — | ||
| Q4 25 | $375.9M | $130.3M | ||
| Q3 25 | $302.3M | $115.3M | ||
| Q2 25 | $293.9M | $104.7M | ||
| Q1 25 | $286.9M | $97.1M | ||
| Q4 24 | $278.7M | $92.1M | ||
| Q3 24 | $276.1M | $71.1M | ||
| Q2 24 | $264.7M | $48.5M |
总资产CBANPBYI
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.7B | $216.3M | ||
| Q3 25 | $3.2B | $202.9M | ||
| Q2 25 | $3.1B | $194.9M | ||
| Q1 25 | $3.2B | $196.2M | ||
| Q4 24 | $3.1B | $213.3M | ||
| Q3 24 | $3.1B | $220.7M | ||
| Q2 24 | $3.0B | $205.0M |
负债/权益比CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.89× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | $-5.5M | $14.4M | ||
| Q3 25 | $14.4M | $9.7M | ||
| Q2 25 | $15.8M | $14.1M | ||
| Q1 25 | $17.9M | $3.6M | ||
| Q4 24 | $23.4M | $15.6M | ||
| Q3 24 | $20.5M | $11.0M | ||
| Q2 24 | $1.1M | $1.0M |
自由现金流CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | $-6.9M | $14.4M | ||
| Q3 25 | $14.1M | $9.7M | ||
| Q2 25 | $15.8M | $14.1M | ||
| Q1 25 | $17.6M | $3.6M | ||
| Q4 24 | $22.3M | $15.6M | ||
| Q3 24 | $20.2M | $11.0M | ||
| Q2 24 | $990.0K | $1.0M |
自由现金流率CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | -18.7% | 19.1% | ||
| Q3 25 | 42.9% | 17.7% | ||
| Q2 25 | 48.5% | 26.8% | ||
| Q1 25 | 58.7% | 7.7% | ||
| Q4 24 | 72.5% | 26.4% | ||
| Q3 24 | 70.6% | 13.7% | ||
| Q2 24 | 3.5% | 2.1% |
资本支出强度CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 1.2% | 0.1% | ||
| Q4 24 | 3.5% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 0.5% | 0.0% |
现金转化率CBANPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.48× | 1.10× | ||
| Q2 25 | 1.99× | 2.41× | ||
| Q1 25 | 2.71× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.64× | 0.54× | ||
| Q2 24 | 0.20× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
PBYI
暂无分部数据
